AGIO- Agios Pharmaceuticals, Inc.

Name: Agios Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Agios Pharmaceuticals, Inc. (AGIO) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. AGIO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Fouse Jacqualyn A	151.3K	$4.17M	-
Other	Gheuens Sarah	67.7K	$1.86M	-
CFO	Jones Cecilia	40.3K	$1.11M	-
Other	Milanova Tsveta	37.7K	$1.04M	-
Dir	Scadden David	17.6K	$484.6K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 5, 2026	Milanova Tsveta46	Chief Commercial Officer	Sale+OE	2,872	$27.02	$77,601.44	-7.6%	+26.8%	-
Dec 30, 2025	Burns James William49	Chief Legal Officer	Sale+OE	2,932	$27.09	$79,427.88	-8.5%	+8.3%	-
Dec 30, 2025	Goff Brian50	Chief Executive Officer	Sale+OE	18,703	$27.09	$506,664.27	-6.3%	+8.3%	-
Dec 30, 2025	Gheuens Sarah49	Chief Medical Officer	Sale+OE	2,932	$27.09	$79,427.88	-4.3%	+8.3%	-
Dec 30, 2025	Milanova Tsveta46	Chief Commercial Officer	Sale+OE	2,932	$27.09	$79,427.88	-9.1%	+8.3%	-
Dec 30, 2025	Jones Cecilia48	Chief Financial Officer	Sale+OE	2,932	$27.09	$79,427.88	-7.3%	+8.3%	-
Nov 12, 2025	Scadden David75	Director	Sale+OE	200	$43.84	$8,768.00	-1.1%	-37.8%	-
Nov 11, 2025	Gheuens Sarah49	Chief Medical Officer	Sale+OE	2,454	$43.78	$107,436.12	-3.8%	-38.6%	-
Oct 30, 2025	Gheuens Sarah49	Chief Medical Officer	Sale+OE	200	$43.81	$8,762.00	-0.3%	-34.4%	-
Oct 27, 2025	Gheuens Sarah49	Chief Medical Officer	Sale+OE	3,302	$43.92	$145,023.84	-5.1%	-33.1%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC